Posted on 8/17/16
Pfizer's Bold Bid to Conquer Cancer
IMAGE SOURCE: GETTY IMAGES.Pfizer Inc. (NYSE:PFE) came up strong last quarter, topping analysts' estimates by a hefty margin. In particular, the world's second biggest drugmaker by . . .
Posted on 8/17/16
Immune Pharmaceuticals Provides Business and R&D Update
Immune Pharmaceuticals Inc. (NASDAQ:IMNP) announced financial results for the second quarter and six months ended June 30, 2016 as well as provided pipeline highlights and a business . . .
Posted on 8/17/16
Arno Completes $2.8 Million Private Placement
FLEMINGTON, N.J.--(BUSINESS WIRE)--Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company primarily focused on the development of therapeutics for cancer and other life threatening diseases, today . . .
Posted on 8/16/16
Advaxis Secures a $30M Direct Placement Financing to Healthcare Specialist Investors
PRINCETON, N.J., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today announced that it has entered into a . . .
Posted on 8/16/16
CHI Franciscan Health and CityMD Open First Urgent Care Center in Seattle
CHI Franciscan Health, a leading health care provider in the Pacific Northwest, and CityMD, the largest urgent care provider in the metro New York area, opened . . .
Posted on 8/16/16
Partnership for a Drug-Free Texas Joins the Partnership for Drug-Free Kids as New National Alliance Partner
The Partnership for Drug-Free Kids, a national nonprofit committed to helping families struggling with their son or daughter's substance use, announced today that Partnership for a . . .
Posted on 8/16/16
Aetna to Narrow Individual Public Exchange Participation
HARTFORD, Conn.--(BUSINESS WIRE)--Aetna (NYSE: AET) Chairman and CEO Mark T. Bertolini made the following statement with regard to the company’s 2017 participation in the Affordable Care . . .
Posted on 8/15/16
Celsion Corp. Reports Q2 2016 Financial Results and Provides Business Update
Celsion Corporation (NASDAQ:CLSN), an oncology drug development company, today announced financial results for the quarter and six month period ended June 30, 2016 and provided an . . .
Posted on 8/15/16
How Risky Is Celldex Therapeutics, Inc.?
IMAGE SOURCE: GETTY IMAGES.Tiny Celldex Therapeutics (NASDAQ:CLDX) is punching above its weight, as it develops one of the industry's more impressive clinical-stage oncology pipelines. With five . . .
Posted on 8/15/16
Bristol-Myers' Revolutionary Cancer Drug Suffers A Big Blow
Bristol-Myers Squibb's(NYSE:BMY) Opdivo is approved to treat some patients who see their lung cancer return following chemotherapy, but a key trial evaluating Opdivo's use in previously . . .
Posted on 8/15/16
Echo Therapeutics Announces Second Quarter 2016 Financial Results
Echo Therapeutics, Inc. (OTCQB: ECTE), a medical device company focused on non-invasive continuous glucose monitoring (CGM) and associated technologies, today announced its financial results for the . . .
Posted on 8/11/16
After Opdivo's Failure, Is Merck a Better Buy Than Bristol-Myers?
IMAGE SOURCE: GETTY IMAGES.Bristol-Myers Squibb's (NYSE:BMY) Opdivo failed to deliver the goods in a key lung cancer trial, causing Bristol-Myers' shares to plummet. The failure also . . .
Posted on 8/11/16
TrialScope Adds Four New Customers to Growing Base
TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced it has added four new customers from across the life sciences industry. The . . .
Posted on 8/11/16
Misonix Announces Agreement with SonoSpine
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical . . .
Posted on 8/10/16
Fortress Biotech Reports Second Quarter 2016 Financial Results and Recent Corporate Highlights
NEW YORK, Aug. 09, 2016 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ:FBIO), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, . . .
Posted on 8/10/16
Agadia Systems Announces Agreement with Serve You Custom Rx Management
Agadia Systems, Inc. (Agadia), known for its innovative utilization management solutions used by the nation's leading Health Plans and PBMs, andServe You Custom Rx Management (Serve . . .
Posted on 8/9/16
U.S. News & World Report Names Hartford Hospital Best in Hartford Metro Region
Hartford Hospital has been ranked #1 in the Hartford region and among the best in Connecticut for 2016-2017 by U.S. News & World Report. The annual . . .
Posted on 8/9/16
Eagle Pharmaceuticals Reports Second Quarter 2016 Results
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) today announced its financial results for the three- and six-months ended June 30, 2016. Highlights of and subsequent to . . .
Posted on 8/9/16
Abeona Therapeutics, EB Research Partnership and EB Medical Research Foundation to Collaborate on Epidermolysis Bullosa Treatments
Abeona Therapeutics Inc, a clinical-stage biopharmaceutical company focused on delivering gene and plasma-based therapy for life-threatening rare diseases, EB Research Partnership (EBRP) and EB Research Medical . . .
Posted on 8/9/16
Bellerophon Provides Business Update
WARREN, N.J., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today reported financial results for the second quarter ended June . . .
Posted on 8/8/16
SCYNEXIS Reports Second Quarter 2016 Financial Results and Provides Company Update
JERSEY CITY, N.J., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Drug development company SCYNEXIS, Inc. (Nasdaq:SCYX), a pharmaceutical company developing novel anti-infectives, today reported financial results for . . .
Posted on 8/8/16
Celgene and Novartis Lift Juno Therapeutics' Q2 Results
IMAGE SOURCE: GETTY IMAGES.Owning a clinical-stage biotech stock can sometimes be like riding a roller coaster. Juno Therapeutics (NASDAQ:JUNO) shareholders have gotten to experience how apt . . .
Posted on 8/8/16
3 Biotech Stocks to Buy in August
IMAGE SOURCE: GETTY IMAGES.It's been an awful year to be a biotech shareholder. The market-cap-weighted iShares Nasdaq Biotechnology ETF has bounced off some scary low points . . .
Posted on 8/5/16
Better Buy: Merck & Co. Inc. vs. Eli Lilly
IMAGE SOURCE: GETTY IMAGES.Over the past decade, the iShares U.S. Pharmaceuticals ETF has risen a stunning 211%, trouncing the broad market S&P 500 benchmark's gain of . . .
Posted on 8/5/16
Palatin Technologies Closes $9.2 Million Financing
Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics
New York
